CD4 and myeloid sarcoma: In contrast, a more balanced pattern was observed for both CD4+ T cells and WB; a much lower number of CpG-sites, 55% and 52.5%, respectively showed evidence for hypermethylation in MS patients, compared to controls (Table 2 and Table 4 respectively).